Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Doherty

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
BMJ Open|July 5, 2024
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET CollaborationKristy P Robledo, Shilo Lefresne, Yu Yang Soon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2026
Osimertinib and stereotactic radiosurgery for brain metastases in EGFR mutated lung cancer - The STARLET joint analysis of OUTRUN and LUOSICNS randomised trialsChee Khoon Lee, Shilo Lefresne, Yu Yang Soon, et al.
Tuberculosis (Edinburgh, Scotland)|February 3, 2005
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosisAnn Williams, Graham J Hatch, Simon O Clark, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019Joanna Gotfrit, Rachel Goodwin, Timothy Asmis, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics|February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
BMJ Open|July 5, 2024
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET CollaborationKristy P Robledo, Shilo Lefresne, Yu Yang Soon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2026
Osimertinib and stereotactic radiosurgery for brain metastases in EGFR mutated lung cancer - The STARLET joint analysis of OUTRUN and LUOSICNS randomised trialsChee Khoon Lee, Shilo Lefresne, Yu Yang Soon, et al.
Tuberculosis (Edinburgh, Scotland)|February 3, 2005
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosisAnn Williams, Graham J Hatch, Simon O Clark, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019Joanna Gotfrit, Rachel Goodwin, Timothy Asmis, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics|February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 15